190 related articles for article (PubMed ID: 24141536)
21. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
[TBL] [Abstract][Full Text] [Related]
22. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
[TBL] [Abstract][Full Text] [Related]
24. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
25. Reactivity of pulmonary circulation and right ventricle function to inhaled nitric oxide in systemic sclerosis patients.
Plazak W; Gryga K; Sznajd J; Wilisowska J; Czarnobilska E; Goncerz G; Podolec P; Musial J
Clin Rheumatol; 2012 Jan; 31(1):99-104. PubMed ID: 21670950
[TBL] [Abstract][Full Text] [Related]
26. Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
J Dermatol; 2015 Jun; 42(6):625-8. PubMed ID: 25808574
[TBL] [Abstract][Full Text] [Related]
27. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time.
Dogan M; Efe TH; Cimen T; Ozisler C; Felekoglu MA; Ertem AG; Erat M; Yiginer O; Tulmac M
Lung; 2018 Apr; 196(2):173-178. PubMed ID: 29445936
[TBL] [Abstract][Full Text] [Related]
29. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
[TBL] [Abstract][Full Text] [Related]
31. Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis.
Pellicano C; Leodori G; Colalillo A; Navarini L; Gigante A; Rosato E
Clin Exp Med; 2022 Aug; 22(3):421-426. PubMed ID: 34462844
[TBL] [Abstract][Full Text] [Related]
32. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
[TBL] [Abstract][Full Text] [Related]
33. Circulating adipokines and organ involvement in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Batura-Gabryel H; Katulska K; Wojciech S; Trzybulska D; Hrycaj P
Acta Reumatol Port; 2015; 40(2):156-62. PubMed ID: 26219969
[TBL] [Abstract][Full Text] [Related]
34. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
[TBL] [Abstract][Full Text] [Related]
35. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
36. Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma.
Kiatchoosakun S; Wongvipaporn C; Nanagara R; Hoit BD
Clin Cardiol; 2011 Aug; 34(8):488-93. PubMed ID: 21717471
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Hasegawa M; Takehara K; Sato S
Clin Exp Rheumatol; 2008; 26(4):659-62. PubMed ID: 18799101
[TBL] [Abstract][Full Text] [Related]
38. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
39. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.
Thakkar V; Patterson KA; Stevens W; Wilson M; Roddy J; Sahhar J; Proudman S; Hissaria P; Nikpour M
Clin Rheumatol; 2018 Jun; 37(6):1563-1571. PubMed ID: 29687288
[TBL] [Abstract][Full Text] [Related]
40. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
Bosello S; Basile U; De Lorenzis E; Gulli F; Canestrari G; Napodano C; Parisi F; Pocino K; Di Mario C; Tolusso B; Ferraccioli G; Gremese E
J Clin Pathol; 2018 Jul; 71(7):620-625. PubMed ID: 29447111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
